Company: NKLR
Filing Date: 2025-11-10
Form Type: S-1
Source: 0001213900-25-108246
Chunk: 220

Company: Terra Innovatum Global N.V.
Filing Date: 2025-11-10
Form: S-1
Chunk 220
---
   |     | $          |     (0.01 | ) |

<div align='center'>F-13

GSR III ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
(Unaudited)</div>

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES(cont.)

Stock-Based Compensation

The Company recognizes compensation
costs resulting from the issuance of stock-based awards to directors as an expense in the financial statement over the requisite service
period based on a measurement of fair value for each stock-based award. The fair value is amortized as compensation cost on a straight-line
basis over the requisite service period of the awards. The Black-Scholes-Merton option-pricing model includes various assumptions, including
the fair market value of the estimated stock price of the Company, expected life of shares, the expected volatility and the expected risk-free
interest rate, among others. These assumptions reflect the Company’s best estimates, but they involve inherent uncertainties based
on market conditions generally outside the control of the Company.

Recent Accounting Standards

Management does not believe
that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s
financial statements.

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public
Offering, the Company sold 23,000,000 Units (including underwriters’ over-allotment exercise of 3,000,000 Units) at a purchase price
of $10.00 per Unit, generating gross proceeds of $230,000,000 to the Company which was placed in the Trust Account. Each Unit consists
of one Class A ordinary share and one-seventh of one public right (the “Public Right”). Each whole right entitles the holder
thereof to purchase one Class A ordinary share at a price of $10.00 per share. No fractional rights will be issued upon separation of
the Units and only whole rights will trade. The underwriters have exercised their over-allotment option on consummation of the Initial
Public offering to purchase 3,000,000 additional units to cover over-allotments.

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the consummation
of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (“Private Placement”)
of 422,500 units (including underwriters’ over-allotment exercise of 7,500 Units at a price of